Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1267493.RAgMXq_mMs7FfRcxK0vaSZGacCeBQt5NH22XXDL0g0-is130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1267493.RAgMXq_mMs7FfRcxK0vaSZGacCeBQt5NH22XXDL0g0-is130_assertion type Assertion NP1267493.RAgMXq_mMs7FfRcxK0vaSZGacCeBQt5NH22XXDL0g0-is130_head.
- NP1267493.RAgMXq_mMs7FfRcxK0vaSZGacCeBQt5NH22XXDL0g0-is130_assertion description "[Contrary to previous reports, no HLA class I associations with EBV(+) PTLD were found, whereas for cHL known HLA class I associations were confirmed, with HLA-A*02 homozygous individuals having the lowest odds of developing EBV(+) cHL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1267493.RAgMXq_mMs7FfRcxK0vaSZGacCeBQt5NH22XXDL0g0-is130_provenance.
- NP1267493.RAgMXq_mMs7FfRcxK0vaSZGacCeBQt5NH22XXDL0g0-is130_assertion evidence source_evidence_literature NP1267493.RAgMXq_mMs7FfRcxK0vaSZGacCeBQt5NH22XXDL0g0-is130_provenance.
- NP1267493.RAgMXq_mMs7FfRcxK0vaSZGacCeBQt5NH22XXDL0g0-is130_assertion SIO_000772 25731678 NP1267493.RAgMXq_mMs7FfRcxK0vaSZGacCeBQt5NH22XXDL0g0-is130_provenance.
- NP1267493.RAgMXq_mMs7FfRcxK0vaSZGacCeBQt5NH22XXDL0g0-is130_assertion wasDerivedFrom befree-2016 NP1267493.RAgMXq_mMs7FfRcxK0vaSZGacCeBQt5NH22XXDL0g0-is130_provenance.
- NP1267493.RAgMXq_mMs7FfRcxK0vaSZGacCeBQt5NH22XXDL0g0-is130_assertion wasGeneratedBy ECO_0000203 NP1267493.RAgMXq_mMs7FfRcxK0vaSZGacCeBQt5NH22XXDL0g0-is130_provenance.